Neurotherapeutics are the drugs used for the treatment of psychological, psychiatric, and nervous disorders. In recent years there has been rapid progress in advancing new treatments for neurologic and psychiatric disorders. New therapeutics have emerged for the treatment of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, schizophrenia, bipolar illness, depression, and drug abuse disorders. Progress in neurotherapeutics has occurred in concert with progress in basic science methodologies, neuroimaging, clinical trial design, and trial analysis. The objective of neurotherapeutic drug discovery and development is to identify new treatments that will improve the quality of life (QOL) of patients suffering from neurologic and psychiatric illness

  • Current and Future Therapies
  • Delivery of Neurotherapeutics
  • Stem Cells as neurotherapeutics
  • Drugs for neurological disorders

Related Conference of Neurotherapeutics

August 29-31, 2017

15th European Neurology Congress

London, UK
August 29-31, 2017

6th World Congress on Addiction Disorder & Addiction Therapy

Prague, Czech Republic
August 31-September 01, 2017

3rdInternational Conference on Epilepsy and Treatment

Brussels, Belgium
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
September 17-18, 2018

International Conference on Nervous System and Nerve Diseases

Philadelphia , USA
August 29-30, 2018

4th World Congress on Parkinsons and Huntington Disease

Zurich, Switzerland
September 10-12, 2018

4th International Conference on Spine and Spinal Disorders

Dublin, Ireland
September 17-18, 2018

4th World Congress on Epilepsy and Treatment

Bali, Indonesia
November 5-6, 2018

3rd International Conference on Spine and Spinal Disorder

San Franciso, USA

Neurotherapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in